Matthew Pauls - 02 Jul 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (PTHS)

Role
Director
Signature
/s/ Matthew Pauls
Issuer symbol
PTHS
Transactions as of
02 Jul 2025
Transactions value $
$0
Form type
4
Filing time
07 Jul 2025, 21:45:34 UTC
Previous filing
07 Jul 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pauls Matthew Director C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Matthew Pauls 07 Jul 2025 0001573429

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTHS Restricted Stock Units Award +25.5K 25.5K 02 Jul 2025 Common Stock 25.5K $13.50 Direct F1
transaction PTHS Stock Option Award +77.6K 77.6K 02 Jul 2025 Common Stock 77.6K $13.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 25,478 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
F2 On July 2, 2025, the Reporting Person was granted stock options to purchase 77,640 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2025, and in equal installments on a quarterly basis thereafter over a period of two (2) years.